Rmb Capital Management, LLC Repligen Corp Transaction History

Rmb Capital Management, LLC

  • $4.3 Billion
  • Q3 2024

A detailed history of Rmb Capital Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Rmb Capital Management, LLC holds 113,212 shares of RGEN stock, worth $16.4 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
113,212
Previous 112,527 0.61%
Holding current value
$16.4 Million
Previous $14.2 Million 18.77%
% of portfolio
0.39%
Previous 0.35%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$119.79 - $167.35 $82,056 - $114,634
685 Added 0.61%
113,212 $16.8 Million
Q2 2024

Aug 13, 2024
BUY
$120.0 - $182.95 $116,040 - $176,912
967 Added 0.87%
112,527 $14.2 Million
Q1 2024

May 14, 2024
BUY
$170.78 - $208.42 $786,441 - $959,774
4,605 Added 4.31%
111,560 $20.5 Million
Q4 2023

Feb 14, 2024
BUY
$114.17 - $185.35 $62,450 - $101,386
547 Added 0.51%
106,955 $19.2 Million
Q3 2023

Nov 13, 2023
BUY
$138.78 - $176.51 $526,808 - $670,031
3,796 Added 3.7%
106,408 $16.9 Million
Q2 2023

Aug 11, 2023
BUY
$138.42 - $180.31 $253,862 - $330,688
1,834 Added 1.82%
102,612 $14.5 Million
Q1 2023

May 11, 2023
BUY
$154.26 - $198.1 $543,612 - $698,104
3,524 Added 3.62%
100,778 $17 Million
Q4 2022

Feb 14, 2023
SELL
$162.42 - $220.56 $1.83 Million - $2.49 Million
-11,282 Reduced 10.39%
97,254 $16.5 Million
Q3 2022

Nov 14, 2022
SELL
$160.42 - $256.21 $124,806 - $199,331
-778 Reduced 0.71%
108,536 $20.3 Million
Q2 2022

Aug 01, 2022
BUY
$140.68 - $188.02 $648,675 - $866,960
4,611 Added 4.4%
109,314 $17.8 Million
Q1 2022

May 06, 2022
BUY
$161.19 - $257.96 $1.85 Million - $2.97 Million
11,496 Added 12.33%
104,703 $19.7 Million
Q4 2021

Jan 26, 2022
SELL
$247.59 - $304.47 $846,262 - $1.04 Million
-3,418 Reduced 3.54%
93,207 $24.7 Million
Q3 2021

Oct 20, 2021
SELL
$194.77 - $324.21 $329,356 - $548,239
-1,691 Reduced 1.72%
96,625 $27.9 Million
Q2 2021

Aug 13, 2021
BUY
$165.87 - $220.95 $363,752 - $484,543
2,193 Added 2.28%
98,316 $19.6 Million
Q1 2021

May 12, 2021
BUY
$180.37 - $226.26 $629,310 - $789,421
3,489 Added 3.77%
96,123 $18.7 Million
Q4 2020

Feb 11, 2021
SELL
$148.08 - $206.57 $1.67 Million - $2.33 Million
-11,269 Reduced 10.85%
92,634 $17.8 Million
Q3 2020

Nov 10, 2020
BUY
$122.51 - $158.27 $477,421 - $616,778
3,897 Added 3.9%
103,903 $15.3 Million
Q2 2020

Aug 05, 2020
BUY
$94.33 - $140.48 $145,928 - $217,322
1,547 Added 1.57%
100,006 $12.4 Million
Q1 2020

May 11, 2020
BUY
$84.96 - $109.14 $1.13 Million - $1.45 Million
13,305 Added 15.62%
98,459 $9.51 Million
Q4 2019

Feb 13, 2020
BUY
$73.84 - $93.08 $58,702 - $73,998
795 Added 0.94%
85,154 $7.88 Million
Q3 2019

Nov 12, 2019
BUY
$76.65 - $95.51 $306,523 - $381,944
3,999 Added 4.98%
84,359 $6.47 Million
Q2 2019

Aug 13, 2019
SELL
$54.2 - $85.95 $1.37 Million - $2.17 Million
-25,248 Reduced 23.91%
80,360 $6.91 Million
Q1 2019

May 15, 2019
BUY
$49.45 - $62.8 $593,647 - $753,914
12,005 Added 12.83%
105,608 $6.24 Million
Q4 2018

Feb 13, 2019
SELL
$48.26 - $68.88 $534,431 - $762,777
-11,074 Reduced 10.58%
93,603 $4.94 Million
Q3 2018

Nov 14, 2018
SELL
$46.8 - $58.97 $614,858 - $774,747
-13,138 Reduced 11.15%
104,677 $5.81 Million
Q2 2018

Aug 13, 2018
SELL
$35.26 - $47.04 $1.99 Million - $2.65 Million
-56,383 Reduced 32.37%
117,815 $0
Q1 2018

May 14, 2018
SELL
$30.92 - $37.27 $1.15 Million - $1.38 Million
-37,092 Reduced 17.56%
174,198 $6.3 Million
Q4 2017

Feb 14, 2018
BUY
$32.53 - $38.92 $26,349 - $31,525
810 Added 0.38%
211,290 $7.67 Million
Q3 2017

Nov 14, 2017
BUY
$36.98 - $46.06 $1.17 Million - $1.46 Million
31,590 Added 17.66%
210,480 $8.07 Million
Q2 2017

Aug 14, 2017
BUY
N/A
178,890
178,890 $7.41 Million

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Rmb Capital Management, LLC Portfolio

Follow Rmb Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rmb Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email